ArticleFrontiers in immunology2026

Novel application for the JAK inhibitor baricitinib in the treatment of Vogt-Koyanagi-Harada disease: a prospective cohort study.

Huan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.